Amonafide in Treating Women With Metastatic Breast Cancer That Has Progressed After Previous Chemotherapy

Completed · Phase 2

Conditions studied: Breast Cancer

In brief

RATIONALE: Drugs used in chemotherapy, such as amonafide, work in different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of amonafide in treating women who have metastatic breast cancer that has progressed after previous chemotherapy.

Key facts

Study ID

NCT00074100

Run by

Memorial Sloan Kettering Cancer Center

Starts

2003-08-01

Expected to finish

2004-09-01

Last updated by the study team

2013-05-30

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

Where it is running

• Memorial Sloan-Kettering Cancer Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.